StockTipsArenaBeta

BUY Global Health Limited — Rajesh Agarwal, AUM Capital

BUYGlobal Health Limited
Global Health share price target & all analyst calls

byRajesh Agarwal, AUM CapitalHorizon: NA (inferred 1 year)18 Sept 2026via CNBC Awaaz.

Entry₹1,493.1Inferred
Target₹1,800
Total upside +20.55%
Stop lossNot given
CMP₹1,387.61d ago
Active-7.07%+29.72%upside left 10 mo left
Follow Rajesh Agarwal for new callsGet alertsWatch MEDANTA for new buy/sell callsGet alertsSee 8 other Long-term calls on MEDANTASee 542 other Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 7 Nov, 5:27 pm IST
22 supporting8 neutral3 opposing
Supports the BUY call (22)

Long-term trend bullish — 200-day average rising over the past quarter

Technicals · trend·6 Nov · yesterday

3 advisors have active short-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · adjacent horizon·5 Nov · 2d ago

8 other SEBI-registered advisors have active long-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · same horizon·5 Nov · 2d ago

Global Health reported Q2 FY27 revenue of INR 14,690 million (up 33.6% y-o-y) and PAT of INR 2,191 million (up 38.3% y-o-y). The board also approved a 500-bed hospital project in Ghaziabad.

BSE · Company Update·3 Nov · 4d ago

(opens in new tab)

Fortis Healthcare, Apollo Hospitals, Max, Medanta shares rise: Should investors buy after 30% cancer drug price cap?

NewsLivemint·9 Oct · 4w ago

(opens in new tab)
Neutral / worth noting (8)

Outcome of Board Meeting held on November 03, 2026, to consider and approved the unaudited financial Results for the Quarter & Half year ended September 30, 2026.

BSE · Board Meeting·3 Nov · 4d ago

(opens in new tab)
Weighs against the BUY call (3)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Global Health

All analyst calls on Global Health

More from Rajesh Agarwal, AUM Capital

Every call and its outcome